Observational longitudinal cohort study to determine progression to heart failure in a screened community population: The Echocardiographic Heart of England Screening Extension (ECHOES-X) study

BMJ Open

Volumn 4, Issue 7, 2014, Pages

  Taylor, Clare J ^a   Roalfe, Andrea K ^a   Tait, Lynda ^a   Davis, Russell C ^b   Iles, Rachel ^a   Derit, Marites ^a   Hobbs, F D Richard ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; ARTICLE; COHORT ANALYSIS; DIAGNOSIS RELATED GROUP; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC DYSFUNCTION; DISEASE COURSE; DIURETIC THERAPY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; RESCREENING; SENSITIVITY AND SPECIFICITY; SURVIVOR; UNITED KINGDOM; AGED; BLOOD; DIAGNOSTIC IMAGING; ECHOGRAPHY; ENGLAND; MASS SCREENING; MIDDLE AGED;

AGED; COHORT STUDIES; DISEASE PROGRESSION; ENGLAND; FEMALE; HEART FAILURE; HUMANS; LONGITUDINAL STUDIES; MALE; MASS SCREENING; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; ULTRASONOGRAPHY;

EID: 84904246510     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005256     Document Type: Article

References (25)

1. Jhund PS, MacIntyre K, Simpson CR, et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 2009;119:515-23.
2. Taylor CJ, Hobbs FDR. Heart failure therapy in patients with coronary artery disease. Curr Opin Pharmacol 2013;13:205-9.
3. Stewart S, MacIntyre K, Hole DJ, et al. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315-22. (Pubitemid 32895839)
4. Jemtel THL, Padaletti M, Jelic S. Diagnostic and therapeutic challenges in patients with co-existent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 2007;49:171-80. (Pubitemid 46054390)
5. European Society of Cardiology. Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012;33:1787-847.
6. Bleumink GS, Knetsch AM, Sturkenboom MCJM, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. Eur Heart J 2004;25:1614-19. (Pubitemid 39209281)
7. Torabi A, Cleland JGF, Khan NK, et al. The timing of development and subsequent clinical course of heart failure after myocardial infarction. Eur Heart J 2008;29:859-70. (Pubitemid 351499497)
8. National Institute for Health and Clinical Excellence. Chronic heart failure-management of chronic heart failure in adults in primary and secondary care. NICE, 2010.
9. Davies M, Hobbs FDR, Davis R, et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population-based study. Lancet 2001;358:439-44. (Pubitemid 32769849)
10. The task force on heart failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995;16:741-51.
11. Taylor CJ, Roalfe AK, Iles R, et al. Ten-year prognosis of heart failure in the community: follow-up data from the Echocardiographic Heart of England Screening (ECHOES) study. Eur J Heart Fail 2012;14:176-84.
12. Gill PS, Calvert M, Davis R, et al. Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). PLoS ONE 2011;6:e26710.
13. Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis and treatment. Eur Heart J 2011;32:670-9.
14. Fonarow GC, Stough WG, Abraham WT, et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 2007;50:768-77. (Pubitemid 47243795)
15. Lee DS, Gona P, Vasan RS, et al . Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction. Insights from the Framingham Heart Study of the National Heart, Lung and Blood Institute. Circulation 2009;119:3070-7.
16. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-50. (Pubitemid 38944258)
17. Roger VL. Epidemiology of heart failure. Circ Res 2013;113:646-59.
18. Westermann D, Kasner M, Steendijk P, et al. Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 2008;117:2051-60. (Pubitemid 351572179)
19. Lam CSP, Donal E, Kraigher-Krainer E, et al. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail 2011;13:18-28.
20. Redfield M, Jacobsen SJ, Burnett JC, et al. Burden of systolic and diastolic ventricular dysfunction in the community. JAMA 2003;289:194-202.
21. Davis RC, Hobbs FDR, Kenkre JE, et al. Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study. Europace 2012;14:1553-9.
22. Taylor CJ, Roalfe AK, Iles R, et al. The potential role of NT-proBNP in screening for and predicting prognosis in heart failure: a survival analysis. BMJ Open 2014;4:e004675.
23. Department of Health. National Service Framework for Coronary Heart Disease. March 2000. https://www.gov.uk/government/publications/quality- standards-for-coronary-heart-disease-care
24. National Institute for Health and Clinical Excellence. Myocardial infarction: secondary prevention. NICE, 2007.
25. Gillinov AM, Mihalijevic T, Blackstone EH, et al. Should patients with severe mitral regurgitation delay surgery until symptoms develop? Ann Thorac Surg 2010;90:481-8.